Johnson & Johnson to develop spine robot to rival medtech competitors

Robotics

Johnson & Johnson is planning to develop its own spine robot to rival the platforms launched by Medtronic, Globus Medical and emerging device companies, company executives said Sept. 7 during the 2022 Wells Fargo Healthcare Conference, according to Seeking Alpha

Ashley McEvoy, executive vice president, worldwide chair of Johnson & Johnson's medtech business, said the company's orthopedics sector — such as hips and trauma — is gaining market share, but spine has been losing ground.

Johnson & Johnson said it will develop a spine robot on the back of the success of its Velys system for total knee replacement, which recently surpassed 10,000 cases, according to the company. 

Ms. McEvoy did not provide a timeline for the robot but said "three important innovations" are expected to reshape the company's spine portfolio "in the next couple of years." 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like